Valuation: CellaVision AB

Market Cap 3.3B 341M 299M 277M 255M 482M 32.63B 491M 1.29B 16.03B 1.28B 1.25B 55.34B P/E 2026 *
24.2x
P/E 2027 * 19.3x
Enterprise Value 3.09B 319M 280M 259M 238M 451M 30.51B 459M 1.21B 14.98B 1.2B 1.17B 51.74B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 3.58x
Free-Float
83.08%
Yield 2026 *
1.99%
Yield 2027 * 2.3%
1 day+0.07%
1 week-5.46%
Current month+1.62%
1 month+0.14%
3 months-8.34%
6 months-12.41%
Current year-11.96%
1 week 132
Extreme 132
144.4
1 month 132
Extreme 132
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 66.75
Extreme 66.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
Jun. 11Buy 760 0.0032%
Jun. 08Buy

Director

314 0.0013%
Jun. 08Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.46%-24.37%-26.23% 342M
+3.10%+10.11%+13.15%-20.54% 17.28B
-2.03%-7.63%+11.71%+93.03% 1.68B
-2.08%-0.61%-38.01%-79.56% 1.25B
+0.40%-6.35%-32.01%+28.29% 1.06B
-1.70%-3.89%-30.46%-54.61% 626M
-0.21%-4.95%-39.99%-56.10% 555M
-2.26%+0.56%+36.19%-53.73% 466M
+1.60%+1.12%-54.14%-59.10% 380M
-1.85%-5.58%+18.30%-0.62% 306M
Average -0.44%-0.81%-13.96%-22.92% 2.4B
Weighted average by Cap. +1.45%+4.52%+4.93%-16.26%

Financials

2026 *2027 *
Net sales 760M 78.52M 68.87M 63.78M 58.69M 111M 7.52B 113M 298M 3.69B 295M 288M 12.75B 851M 87.85M 77.05M 71.36M 65.66M 124M 8.41B 127M 334M 4.13B 330M 323M 14.26B
Net income 136M 14.09M 12.35M 11.44M 10.53M 19.91M 1.35B 20.3M 53.49M 662M 52.89M 51.73M 2.29B 175M 18.09M 15.86M 14.69M 13.52M 25.57M 1.73B 26.07M 68.68M 850M 67.92M 66.43M 2.94B
Net Debt -215M -22.22M -19.49M -18.05M -16.61M -31.42M -2.13B -32.03M -84.38M -1.04B -83.44M -81.62M -3.61B -254M -26.22M -23M -21.3M -19.6M -37.07M -2.51B -37.79M -99.56M -1.23B -98.45M -96.3M -4.26B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-13 SEK 138.40 0.00% 21,004
26-07-10 SEK 138.40 +2.67% 12,538
26-07-09 SEK 134.80 +2.12% 16,039
26-07-08 SEK 132.00 -3.37% 32,326
26-07-07 SEK 136.60 -4.74% 39,551
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
138.40SEK
Average target price
168.75SEK
Spread / Average Target
+21.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock